Cargando…
1-Deoxy-d-galactonojirimycins with dansyl capped N-substituents as β-galactosidase inhibitors and potential probes for G(M1) gangliosidosis affected cell lines
Two simple and reliably accessible intermediates, N-carboxypentyl- and N-aminohexyl-1-deoxy-d-galactonojirimycin were employed for the synthesis of a set of terminally N-dansyl substituted derivatives. Reaction of the terminal carboxylic acid of N-carboxypentyl-1-deoxy-d-galactonojirimycin with N-da...
Autores principales: | Fröhlich, Richard F.G., Furneaux, Richard H., Mahuran, Don J., Saf, Robert, Stütz, Arnold E., Tropak, Michael B., Wicki, Jacqueline, Withers, Stephen G., Wrodnigg, Tanja M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158671/ https://www.ncbi.nlm.nih.gov/pubmed/21645885 http://dx.doi.org/10.1016/j.carres.2011.05.010 |
Ejemplares similares
-
Synthesis of lipophilic 1-deoxygalactonojirimycin derivatives as D-galactosidase inhibitors
por: Schitter, Georg, et al.
Publicado: (2010) -
New α-galactosidase-inhibiting aminohydroxycyclopentanes
por: Weber, Patrick, et al.
Publicado: (2021) -
Synthesis of a New β-Galactosidase Inhibitor Displaying Pharmacological Chaperone Properties for GM1 Gangliosidosis
por: Clemente, Francesca, et al.
Publicado: (2022) -
Intracerebroventricular enzyme replacement therapy with β-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice
por: Chen, Joseph C., et al.
Publicado: (2020) -
Three novel beta-galactosidase gene mutations in Han Chinese patients with GM1 gangliosidosis are correlated with disease severity
por: Yang, Chi-Fan, et al.
Publicado: (2010)